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Memory B Cells without Somatic Hypermutation
Are Generated from Bcl6-Deficient B Cells
forming cells (AFCs) around 1–2 weeks after immuniza-
tion. Memory B cells persist largely without proliferation
(Schittek and Rajewsky, 1990; Gray et al., 1994; Manz
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et al., 1997; Smith et al. 1997; Slifka et al., 1998). Re-Toshitada Takemori,2 Yoshikazu Kuroda,3
cently, many mutant mice generated by gene targetingand Takeshi Tokuhisa1,4
have been found to lack GCs. These include CD40 and1Department of Developmental Genetics (H2)
CD40 ligand (Castigli et al., 1994; Kawabe et al., 1994;Graduate School of Medicine
Xu, et al., 1994), complement receptors (CR1 and CR2)Chiba University
(Ahearn et al., 1996; Croix et al., 1996), CD28 (ShakimanChiba 260-8670
et al., 1993; Ferguson et al., 1996), Lymphotoxin (LT) 2 Department of Immunology
(Banks et al., 1995; Matsumoto et al., 1996), and LynNational Institute of Infectious Diseases
(Kato et al., 1998). In CD40- and CD28-deficient mice,Shinjuku-ku
both Ig class switching and affinity maturation followingTokyo 162-8640
somatic hypermutation of the variable (V ) region genes3 First Department of Surgery
were impaired. In contrast, LT- and Lyn-deficient miceGraduate School of Medicine
exhibited IgG1 responses and affinity maturation afterKobe University
immunization with TD-Ags. Therefore, a role for GCs inKobe 650-0017
affinity maturation and memory B cell development hasJapan
remained controversial.
The Bcl6 gene is ubiquitously expressed in various
tissues, and the expression is predominant in GC cellsSummary
(Cattoretti et al., 1995; Onizuka et al., 1995). The Bcl6
gene encodes a 92 to 98 kDa nuclear phosphoproteinAfter immunization with T cell-dependent antigens,
that contains the BTB/POZ domain in the NH2-terminalthe high-affinity B cells selected in germinal centers
region and Kru¨ppel-type zinc finger motifs in the COOH-differentiate into memory B cells or long-lived anti-
terminal region (Kerckaert et al., 1993; Ye et al., 1993;body-forming cells. However, a role for germinal cen-
Miki et al., 1994; Fukuda et al., 1995). Since the NH2-ters in development of these B lineage cells is still
terminal half of the protein contains repressor domainscontroversial. We show here that Bcl6-deficient B
in vitro (Deweindt et al., 1995; Albagli et al., 1996; Changcells, which cannot develop germinal centers, differ-
et al., 1996; Seyfert et al., 1996), Bcl6 can function as aentiated into IgM and IgG1 memory B cells in the
sequence-specific transcriptional repressor. Indeed, thespleen but barely differentiated into long-lived IgG1
BTB/POZ domain of Bcl6 can bind to the silencing medi-antibody-forming cells in the bone marrow. Mutation
ator of retinoid and thyroid receptors (SMRT) and recruitin the V-heavy gene was null in these memory B cells.
the SMRT/histone deacetylase complex to silencer re-Therefore, Bcl6 and germinal center formation are es-
gions of target genes to repress expression of thesesential for somatic hypermutation, and generation of
genes (Dhordain et al., 1997). To observe physiologicalmemory B cells can occur independently of germinal
functions of Bcl6, its gene was disrupted in the mousecenter formation, somatic hypermutation, and Ig class
germ line (Dent et al., 1997; Ye et al., 1997; Yoshida etswitching.
al., 1999). Bcl6-deficient (Bcl6/) mice showed growth
retardation, and most died at a young adult age. Al-Introduction
though all hematopoietic lineages, including mature
lymphocytes, developed in Bcl6/ mice, GC formation
In response to T cell-dependent antigens (TD-Ags), B was impaired in these mice.
cells are activated by interactions with CD4 helper T To examine the function of mature B cells in Bcl6/
cells in periarteriolar lymphoid sheaths (PALS) in the mice, we developed RAG1-deficient (RAG1/) mice re-
spleen (Hanna, 1964). These activated B cells generate constituted with hematopoietic stem cells in bone mar-
Ab-producing foci in the PALS or migrate into the pri- row (BM) cells of Bcl6/ mice (Bcl6/RM) (Fukuda et
mary follicles to form germinal centers (GCs) (Liu et al., al., 1997). Percentages of B220 B cells, and CD4 or
1991; Kelsoe, 1996). GC B cells proliferate extensively CD8 T cells in the spleen of Bcl6/RM were compara-
and somatically mutate their Ig genes (Berek et al., 1991; ble to those of Bcl6/RM (RAG1/ mice reconstituted
Jacob et al., 1991). The subsequent clonal selection with hematopoietic stem cells of Bcl6/ mice) 3 months
within GC B cells allows for a selective accumulation after transplantation. When we immunized Bcl6/RM
of high-affinity variants through two steps of selection: with TD-Ags, GC formation was impaired in all lymphatic
active loss of low-affinity or autoreactive ones (negative organs of Bcl6/RM examined, including the spleen.
selection) and preferential retention of higher-affinity Bcl6/RM can produce control levels of primary IgM
ones (positive selection) (Kelsoe, 1996; Pulendran et al., and IgG1 Abs until 14 days after immunization. Since
1997). The positively selected B cells with higher affinity the great majority of Abs produced in the first 12 days
differentiate into memory B cells or long-lived antibody- after immunization are derived from PALS-associated
foci (Jacob and Kelsoe, 1992; Smith et al., 1996) and
since Bcl6 expression is not upregulated in PALS-asso-4 Correspondence: tokuhisa@med.m.chiba-u.ac.jp
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Figure 1. Bcl6/RM Produce Control Levels
of Secondary IgG1 Abs with Low Affinity
Bcl6/RM (open circle) and Bcl6/RM
(closed circle) were immunized with NP-CG
in alum (closed triangle) and then boosted
with aqueous NP-CG (open triangle) 70 days
after primary immunization. These mice were
bled after immunization, and the titers of IgG1
and IgM anti-NP Abs in sera were measured
using ELISA.
(A) Titers of IgG1 anti-NP Abs were measured
with NP25-BSA.
(B) Titers of IgG1 anti-NP Abs were measured
with NP2-BSA.
(C) The ratios of the titers detected with NP2-
BSA to those with NP25-BSA.
(D) Titers of IgM anti-NP Abs were measured
with NP25-BSA.
Results represent the mean  SD of five to
seven mice per group. These results are rep-
resentative of three independent experi-
ments.
ciated foci (Fukuda et al., 1997), Bcl6 is not essential time. After boosting, the titers in the Bcl6/RM in-
creased to 7-fold of the primary levels within 7 days.for the focus formation in the PALS by antigen-reactive
B cells. However, development of memory B cells and Surprisingly, the levels of IgG1 anti-NP Abs in the
Bcl6/RM increased within 7 days after secondary im-somatic hypermutation of the V region genes have never
been documented for Bcl6/RM. We show here that munization, and these titers were comparable to those
transferable IgM and IgG1 memory B cells can be gener- of Bcl6/RM. When we boosted Bcl6/RM and
ated in the spleens of Bcl6/RM after primary immuni- Bcl6/RM 90 days after primary immunization, the titers
zation and that there is no somatic hypermutation in the of secondary IgG1 anti-NP Abs increased to approxi-
V-heavy genes of these memory B cells, and we discuss mately 5-fold of the peak levels of their primary re-
the possible roles for GCs in memory B cell development sponses and were similar to those of Bcl6/RM 7 days
and somatic hypermutation. after boosting (data not shown). These results sug-
gested that IgG1 memory B cells were generated in
Bcl6/RM.Results
NP2-BSA as a coating antigen can detect IgG1 Abs with
higher affinity (Takahashi et al., 1998). We measured titersBcl6/RM Produce Secondary IgG1 Abs
of IgG1 anti-NP Abs with higher affinity in these sera usingwith Low Affinity
ELISA with NP2-BSA. The titers in the Bcl6/RM in-We immunized Bcl6/RM and Bcl6/RM with
creased with time after primary immunization and further(4-hydroxy-3-nitrophenyl)acetyl-chicken  globulin (NP-
increased to 10-fold of the peak levels of the primaryCG) in alum and then boosted these mice with aqueous
responses seen after secondary immunization (FigureNP-CG 70 days after primary immunization. Titers of
1B). The titers in the Bcl6/RM, however, did not in-IgG1 anti-NP Abs in sera from these mice were mea-
crease after primary immunization and increased tosured using ELISA with NP25-BSA as a coating antigen.
5-fold of the primary levels after secondary immuniza-Bcl6/RM produced primary IgG1 Abs, and the titers
tion. The ratios of titers detected with NP2-BSA to thosewere similar to those of Bcl6/RM until 14 days after
with NP25-BSA (NP2/NP25) in the Bcl6/RM increasedimmunization (Figure 1A). Although the titers of IgG1
from less than 0.10 to 0.50 within 70 days after primaryanti-NP Abs in the Bcl6/RM were maintained until 70
immunization and to over 0.80 after a secondary onedays after immunization, the titers in the Bcl6/RM de-
creased to the levels in unprimed Bcl6/RM within that (Figure 1C). However, the ratios in the Bcl6/RM were
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less than 0.2 after each immunization, which suggested
abnormalities of affinity maturation of IgG1 anti-NP Abs
in Bcl6/RM.
When we measured titers of IgM anti-NP Abs in these
sera using ELISA with NP25-BSA, the Bcl6/RM pro-
duced primary IgM Abs at levels comparable to those
of the Bcl6/RM until 14 days after immunization (Figure
1D). The titers of IgM anti-NP Abs in the Bcl6/RM
decreased to approximately one-third of the peak levels
of the primary responses in the Bcl6/RM 70 days after
immunization and increased to the peak levels of the
primary responses 7 days after secondary immuniza-
tion. The titers of primary IgM anti-NP Abs in the
Bcl6/RM were maintained until 70 days after immuni-
zation and further increased to 10-fold of the primary
levels within 7 days after secondary immunization. This
strong augmentation of secondary IgM anti-NP Ab pro-
ductions was repeated in Bcl6/RM boosted 90 days
after primary immunization (data not shown). These re-
sults suggested the generation of IgM memory B cells
in Bcl6/RM.
Memory B Cells Are Generated in Bcl6/RM
We examined the production of IgG1 anti-NP Abs by
memory B cells in the spleen of Bcl6/RM using the
adoptive transfer method. B220 B cells (3  107 ) were
enriched from spleen cells of Bcl6/RM and Bcl6/RM
90 days after immunization with NP-CG in alum and
mixed with T cells (1.5  107 ) from spleen cells of
C57BL/6 mice 30 days after immunization with CG in
alum. These cell mixtures were transferred into RAG1/
mice and boosted with aqueous NP-CG 12 hr after trans-
fer. These mice were bled on days 3 and 10 after immuni-
zation, and titers of IgG1 anti-NP Abs in sera were mea- Figure 2. Memory B Cells in Bcl6/RM Are Detected by the Adop-
sured using ELISA with NP25-BSA. The titers of IgG1 tive Transfer Method
anti-NP Abs were undetectable in these cell-transferred Bcl6/RM and Bcl6/RM were immunized with NP-CG. B220 B
RAG1/ mice until 3 days after immunization, sug- cells were isolated from spleen cells of these mice 90 days after
immunization. Purified B cells from NP-CG-primed Bcl6/RM (/)gesting no contamination of long-lived AFCs in trans-
and CG-primed T cells from normal C57BL/6 mice (open circle), Bferred B cells (Figure 2A). The titers clearly increased in
cells from NP-CG-primed Bcl6/RM (/) and CG-primed T cellsRAG1/ mice transferred with NP-primed B cells from
(open square), B cells from naive Bcl6/RM and CG-primed T cellsBcl6/RM or Bcl6/RM together with CG-primed T
(closed circle), B cells from naive Bcl6/RM and CG-primed T
cells 10 days after immunization. The titers of IgG1 anti- cells (closed square), or CG-primed T cells (T) (closed triangle) were
NP Abs with higher affinity were measured in these sera transferred into RAG1/ mice with aqueous NP-CG. These mice
using ELISA with NP2-BSA. The titers were high in the were bled on days 3 and 10 after immunization, and the titers of
IgG1 and IgM anti-NP Abs in sera were measured using ELISA.sera from the NP-primed B cells of Bcl6/RM but were
(A) Titers of IgG1 anti-NP Abs were measured with NP25-BSA.very low in those of Bcl6/RM 10 days after immuniza-
(B) Titers of IgG1 anti-NP Abs were measured with NP2-BSA.tion (Figure 2B). Accordingly, affinities of the IgG1 anti-
(C) Ratios of the titers detected with NP2-BSA to those with NP25-NP Abs produced by the NP-primed B cells from
BSA.
Bcl6/RM and those from Bcl6/RM were high (NP2/ (D) Titers of IgM anti-NP Abs were measured with NP25-BSA.
NP25  0.80) and very low (NP2/NP25  0.1), respectively Results represent the mean  SD of three to four mice per group.
(Figure 2C). Titers of IgG1 anti-NP Abs in RAG1/ mice
transferred with naive B cells from Bcl6/RM or
In the case of IgM anti-NP Ab production, these cell-Bcl6/RM together with CG-primed T cells were very
transferred RAG1/ mice did not produce detectablelow even 10 days after immunization. The titers in-
levels until 3 days after immunization (Figure 2D). Thecreased and were 10-fold higher than those with the T
RAG1/ mice transferred with naive B cells fromcell alone 17 days after immunization but were less than
Bcl6/RM or Bcl6/RM together with CG-primed Tone-tenth of those with the NP-primed B cells (data not
cells produced 8-fold greater amounts of IgM anti-NPshown). Similar results were obtained using B220 B
Abs in the RAG1/ mice transferred with CG-primed Tcells from Bcl6/RM and Bcl6/RM 60 days after pri-
cells without B cells 10 days after immunization. Titersmary immunization (data not shown). These results
of IgM anti-NP Abs in the RAG1/ mice transferredclearly indicate that IgG1 memory B cells can be gener-
with NP-primed B cells from Bcl6/RM or Bcl6/RMated in the spleen without GC formation and suggest
together with CG-primed T cells were approximatelythat Bcl6 and GC formation is essential for generation
of high-affinity memory B cells. 5-fold higher than those with the naive ones, thereby
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suggesting the generation of IgM memory B cells in both
Bcl6/RM and Bcl6/RM.
IgG1/CD38 B Cells in Bcl6/RM Are Resting
Memory B Cells
Memory B cells can be identified in spleen cells of NP-
CG-immunized mice using FACS analysis (Ridderstad
and Tarlinton, 1998; Takahashi et al., 2001). (4-hydroxy-
5-iodo-3-nitrophenyl)acetyl (NIP) binding B220 B cells
that express high levels of IgG1 and CD38 (IgG1high/
CD38) and low levels (IgG1dull/CD38dull) are identified
as memory B cells and GC B cells, respectively. We
attempted to identify NP-specific IgG1 memory B cells
in the spleen of Bcl6/RM 60 days after primary immuni-
zation with NP-CG in alum using FACS analysis. As
shown in Figure 3A, NIP binding B220dull and B220 (R2)
B cells were detected in the spleen of Bcl6/RM and
Bcl6/RM. NIP binding B220 (R2) B cells in the
Bcl6/RM contained IgG1/CD38dull (R3) and IgG1/
CD38 (R4) B cells. R4 B cells were also detected in
the Bcl6/RM. However, R3 B cells were not in the
Bcl6/RM, confirming no GC B cells in Bcl6/RM (Fu-
kuda et al., 1997). These two (R3 and R4) subsets of
NIP binding IgG1 B cells were not detected in spleen
cells of nonimmunized Bcl6/RM and Bcl6/RM. Al-
though a novel somatically mutated NP binding B220/
IgG memory B cell subset has recently been demon-
strated (McHeyzer-Williams et al., 2000; Driver et al.,
2001), NIP binding B220dull B cells detected in the
CD90mix- gated population were IgG1/CD38dull B cells
(data not shown), suggesting that these B cells are not
the B220/IgG1 memory B cells.
The function of memory B cells can be tested by the
secondary antibody response in vitro as described pre-
viously (Schittek and Rajewsky, 1990). To confirm that
these NIP binding IgG1/CD38 (R4) B cells are func-
tionally active memory cells, NIP binding IgG1/CD38
B cells sorted from spleen cells of Bcl6/RM and
Bcl6/RM immunized with NP-CG 60 days earlier were
cultured in the presence of PE-primed T cells from
C57BL/6 mice for 14 days. The culture fluids were ana-
lyzed for the presence of IgG1 anti-NP Abs using ELISA
with NP25-BSA. As shown in Table 1, as few as 250
NIP binding IgG1/CD38 B cells from Bcl6/RM or
Bcl6/RM together with PE-primed T cells produced a
Figure 3. NIP Binding IgG1/CD38 B cells in Bcl6/RM Are Rest-strong IgG1 anti-NP Abs. NIP binding IgG1/CD38dull (R3)
ing Memory B Cells
B cells from Bcl6/RM together with PE-primed T cells
(A) Spleen cells from Bcl6/RM and Bcl6/RM 60 days after immu-
also produced a detectable amount of IgG1 anti-NP nization with NP-CG or from naive Bcl6/RM and Bcl6/RM were
Abs, albeit much smaller than that produced by the isolated, stained, and analyzed. (a) NIP binding B220 (R2) cells
NIP binding IgG1/CD38 B cells. However, NIP binding were detected in the CD90mix (R1) cells (see Experimental Proce-
dures) from immunized Bcl6/RM and Bcl6/RM. (b) IgG1/IgG1/CD38 B cells from Bcl6/RM with PE-primed
CD38dull (R3) and IgG1/CD38 (R4) B cells were detected in the NIPT cells or PE-primed T cells without B cells did not
binding B220 (R2) cells from immunized or naive (nonimmunized)produce detectable levels of IgG1 anti-NP Abs. We fur-
Bcl6/RM and Bcl6/RM. The numbers in the squares of R3 and
ther examined whether or not NIP binding IgG1/CD38 R4 indicate cell numbers per 3  105 of R1 gated cells analyzed.
B cells were long-lived AFCs using ELISPOT assay with These results are representative of three independent experiments.
NP25-BSA. No AFCs producing IgG1 anti-NP Abs were (B) Bcl6/RM and Bcl6/RM 60 days after immunization with NP-
CG were pulsed with BrdU for 3 days. Spleen cells and BM cellsdetected in NIP binding IgG1/CD38 B cells from both
from these mice were isolated and stained. NIP binding IgG1/Bcl6/RM and Bcl6/RM (data not shown), indicating
CD38 (R4) B cells in the spleen cells and B220/IgM pre-B cellsthat NIP binding IgG1/CD38 B cells are functional
in the BM cells were sorted and stained for BrdU. The percentage of
memory B cells. BrdU-labeled cells in sorted cells was counted under a fluorescence
Since memory B cells persist largely without prolifera- microscope. Results represent the mean  SD of three mice per
tion (Schittek and Rajewsky, 1990), the resting state of group.
these NIP binding IgG1/CD38 B cells was examined
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Table 1. In Vitro Secondary Antibody Responses of NIP Binding IgG1/CD38 B Cells in Spleens of Bcl6/RM
B cellsa Anti-NP IgG1 Abs (103 units)b
1 2 3 4Experiment
Bcl6RM / / / / / /
NIP/IgG1/CD38 250 43 37 22 47 30
NIP/IgG1/CD38dull 14 3.4 c ()d  ()
NIP/IgG1/CD38 1 1    
a Spleen cells were isolated from Bcl6/RM and Bcl6/RM 60 days after NP-CG priming and then stained and sorted. The sorted B cells
(Experiment 1, 500 cells per well; experiments 2–4, 250 cells per well) were cultured with PE-primed CD4 T cells (2  105 cells per well) for
14 days.
b Titers of IgG1 anti-NP Abs in culture supernatants were analyzed using ELISA with NP25-BSA.
c Not done.
d The numbers of these B cells were too low to be isolated.
Note that the titers of IgG1 anti-NP Abs in the cultures of PE-primed CD4 T cells without B cells in each experiment were less than 1  103
units.
by labeling the cells with 5-bromo-2	-deoxy-uridine numbers with NP2-BSA were undetectable, and thus the
affinities were very low (NP2/NP25  0.1).(BrdU) in vivo for 3 days. To determine the ratio of labeled
versus unlabeled cells among the NIP binding IgG1/ The titers of primary IgM anti-NP Abs were maintained
in Bcl6/RM but not in Bcl6/RM until 70 days afterCD38 B cells, we collected 1000–2000 cells in this frac-
tion, analyzed the BrdU staining profile, and calculated immunization (Figure 1D), which suggested the genera-
tion of long-lived AFCs producing IgM anti-NP Abs inthe percentage of BrdU-labeled cells in this population.
For positive control of proliferating cells, we collected the BM of Bcl6/RM. When we measured the number
of AFCs producing IgM anti-NP Abs in these BM cellspre-B (B220/IgM) cells from BM cells of the Bcl6/RM
and the Bcl6/RM. Although approximately 70% of the with NP25-BSA, IgM-AFCs were clearly detected in both
the Bcl6/RM and the Bcl6/RM 14 days after immuni-pre-B cells from both mice divided within 3 days, less
than 5% of NIP binding IgG1/CD38 B cells from the zation (Figure 4D). Although with time the numbers de-
creased in both the Bcl6/RM and the Bcl6/RM, theBcl6/RM and the Bcl6/RM were stained, indicating
that a majority of these NIP binding IgG1/CD38 B cells numbers in the Bcl6/RM were larger than those in the
Bcl6/RM 60 days after immunization. These resultsare in the resting state (Figure 3B). These results also
deny the possibility that NIP binding IgG1/CD38 B suggest that IgM-AFCs can be generated in the BM
independently of GC formation and that the term forcells in the spleen of Bcl6/RM are newly generated B
cells by persisting TD-Ags in the absence of a vigorous, IgM-AFCs to be maintained in the BM is shorter than
that for IgG1-AFCs in the BM.high-affinity antibody response.
Long-Lived AFCs Producing IgG1 Abs Are Barely Memory B Cells Generated in Bcl6/RM
Have No Somatic HypermutationGenerated in Bcl6/RM
Long-lived AFCs producing IgG1 Abs are generated In C57BL/6 mice, anti-NP responses are dominated by
Abs composed of a 
1 L chain and an H chain whosefrom GC B cells and continuously produce IgG1 Abs in
the BM after primary immunization (Manz et al., 1997; variable region is encoded by the V segment, V186.2,
rearranged to a D segment, DFL16.1 (Bothwell et al.,Smith et al. 1997; Slifka et al., 1998; Takahashi et al.,
1998). Although the titers of primary IgG1 anti-NP Abs 1982; Cumano and Rajewsky, 1985). The tryptophan
(Trp) to leucine (Leu) mutation at position 33 along within Bcl6/RM were maintained until 70 days after primary
immunization (Figure 1D), the titers in Bcl6/RM de- tyrosine (Tyr) at position 99 (Leu33/Tyr99) emerges in
the early primary response (Cumano and Rajewsky,creased to the levels in unprimed Bcl6/RM within that
time, suggesting that the generation of long-lived AFCs 1985; Allen et al., 1988; Weiss and Rajewsky, 1990; Ja-
cob and Kelsoe, 1992; Furukawa et al., 1999). Sinceis impaired in Bcl6/RM. We next examined the genera-
tion of long-lived AFCs in the BMs of Bcl6/RM and Bcl6/RM produced control levels of primary and sec-
ondary IgG1 anti-NP Abs with low affinity (Figure 1), andBcl6/RM 14 and 60 days after immunization with NP25-
BSA and NP2-BSA using ELISPOT assay. AFCs produc- the majority had the 
1 L chain (the ratios of 
1/IgG1 in
anti-NP Abs were 0.95  0.23 in Bcl6/RM and 1.05 ing IgG1 anti-NP Abs were detected in Bcl6/RM 14
and 60 days after immunization, and the numbers in 0.23 in Bcl6/RM 14 days after primary immunization),
we examined somatic hypermutation of the V-heavythe BM increased with time (Figures 4A and 4B). The
affinities of IgG1 anti-NP Abs produced by the AFCs gene of NP-specific memory B cells in Bcl6/RM and
Bcl6/RM 60 days after immunization with NP-CG inwere very high (NP2/NP25  0.60 on day 14 and 0.82 on
day 60) (Figure 4C). AFCs producing IgG1 anti-NP Abs alum. A single cell of NIP binding IgG1 or IgM B cells
was sorted from spleen cells of immunized Bcl6/RMwere barely detected in Bcl6/RM 14 days after immu-
nization with NP25-BSA. The small numbers (1–2 cells and Bcl6/RM by FACS and subjected to PCR that
preferentially amplifies the rearranged V-heavy gene en-per 5  105 BM cells) of IgG1-AFCs were maintained in
the BM until 60 days after immunization. However, the coded by the V186.2 subfamily (Takahashi et al., 1998).
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was dominant in both 1 and  clones. We examined
more than 130 independent clones from single sorted
B cells in the spleens of three independent immunized
Bcl6/RM, and more than 90% of the sequenced clones
were VH186.2 (data not shown). In contrast, we ob-
served that only 19% (3/16) of the rearranged V-heavy
genes in NIP binding IgG1 B cells from nonimmunized
mice utilized VH186.2, and all of these rearranged
VH186.2 genes encoded the heterogeneous amino acids
at position 99, other than Tyr99 or glycine 99 (data not
shown). Therefore, it seems unlikely that the presence of
nonmutated B cells represents contamination by naive B
cells. These results strongly suggest that Bcl6 and GC
formation is essential for somatic hypermutation of the
V-heavy genes in memory B cells.
Discussion
The present study demonstrates that Bcl6/RM without
GC formation can produce normal levels of secondary
IgG1 Abs, in agreement with previous observations
that secondary IgG1 production can be detected in
LT-deficient (Matsumoto et al., 1996) and Blr1-deficient
(Forster et al., 1996) mice immunized with soluble TD-
Ags with adjuvant, which suggests the generation of
IgG1 memory B cells without GC formation. However,
LT-deficient mice show dramatically reduced IgG re-
sponses after either primary or secondary immuniza-
tions with sheep red blood cells as an antigen without
adjuvant (Fu et al., 1997), and the microenvironment that
develops in LT-deficient mice is inadequate to support
the activation of this memory response (Fu et al., 2000).
Figure 4. Long-Lived AFCs Producing IgG1 Abs Are Barely De- In Blr1-deficient mice, the migration of lymphocytes into
tected in the BM of Bcl6/RM splenic follicles is severely impaired, resulting in mor-
Generation of long-lived AFCs was examined in the BMs of phologically altered primary lymphoid follicles (Forster
Bcl6/RM (/) and Bcl6/RM (/) 14 and 60 days after immuni- et al., 1996), and ectopic GCs develop in the PALS upon
zation using ELISPOT assay.
immunization with TD-Ags (Voigt et al., 2000). Thus, a(A) Numbers of AFCs producing IgG1 anti-NP Abs were measured
role for GCs in memory B cell development was notwith NP25-BSA.
(B) Numbers of AFCs producing IgG1 anti-NP Abs were measured completely clear in previous studies on LT- and Blr1-
with NP2-BSA. deficient mice. In Bcl6/RM, primary B cell follicles,
(C) Ratios of the numbers measured with NP2-BSA to those with marginal zones, and the PALS were histologically normal
NP25-BSA. in the spleen; control levels of primary IgM and IgG1
(D) Numbers of AFCs producing IgM anti-NP Abs were measured
Abs were produced until 14 days after immunization;with NP25-BSA.
and GC formation was impaired in any lymphatic organsResults represent the mean  SD of three to four mice per group.
The numbers of IgG1-AFCs and IgM-AFCs in the BMs from naive examined (Fukuda et al., 1997). These results indicate
Bcl6/RM and Bcl6/RM were less than one cell per 5  105 BM that a role for GCs in memory B cell development can
cells. These results are representative of two to three independent be elucidated clearly in Bcl6/RM.
experiments. Memory B cells are generally characterized by an acti-
vated cell surface phenotype, a long life span, a resting
state, class-switched Ig, the somatically mutated VSomatic hypermutation accumulated in the rearranged
VH186.2 genes of IgG1 and IgM B cells in Bcl6/RM genes, and a preferential differentiation into plasma cells
(Liu et al., 1988; Schittek and Rajewsky, 1990; Tangye(Table 2). The majority of 1 clones (78%) from
Bcl6/RM carried Leu33. CDRs of the 1 clones (3.41) et al., 1998; Takahashi et al., 2001). We showed here
the generation of IgG1 memory B cells in the spleen ofcontained a 135% higher mutation frequency than those
of  clones (1.45) from Bcl6/RM. Replacement (R) to Bcl6/RM by adoptive transfer experiments and sur-
face phenotype (IgG1/CD38) analysis. Functionalsilence mutation (S) ratios of the 1 clones were higher
in CDR (7.36) than in the framework region (1.52). The IgG1 memory B cells were detected in the spleen of
Bcl6/RM 60 days (Table 1) or 90 days (Figure 2) afterLeu33/Tyr99 and the Trp33/Tyr99 group were dominant
in the 1 and the  clones, respectively. All these obser- primary immunization and were in the resting state (Fig-
ure 3). Since no proliferating B cells with GC phenotypesvations indicate that affinity maturation occurs normally
in Bcl6/RM. However, no somatic hypermutation was were detected in the primary follicles of Bcl6/ mice (Ye
et al., 1997) and in the lymphatic organs of Bcl6/RMdetected in the rearranged VH186.2 genes of IgG1 and
IgM B cells in Bcl6/RM, and the Trp33/Tyr99 group (Fukuda et al., 1997) after primary immunization, we have
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Table 2. Somatic Hypermutation and Clonal Characters in Rearranged VH186.2 Sequencesa
VH186.2 genes
Mutation frequencyb R/Sc
Clonal characters (%)d
DFL16.1 Residue 33/99
Total CDR12 FW Total CDR12 FW
Totale Mutf (213 bp) (69 bp) (144 bp) (5.6)g (3.1) Trp/Tyr Leu/Tyr Trp/Gly
1 /RM 27 24 5.74 3.41 2.33 3.50 7.36 1.52 55.6 14.8 70.4 14.8
1 /RM 72 1 0.01 1/72 0.01 h   54.2 83.3 1/72 1/72
 /RM 20 13 2.85 1.45 1.35 6.86  2.86 60.0 70.0 15.0 5.0
 /RM 60 1 0.02 1/60 0.02    58.3 85.0 1/60 1/60
a Nucleotide exchange frequency in the VH186.2 segments of 1 and  transcripts. Nucleotide replacements at the V-D junctions were not
scored as mutations. Dinucleotide replacements in a codon were counted as one.
b Mutation frequency was calculated by dividing the accumulation number of mutation in a given region. FW; framework.
c R/S indicates the ratio of replacement to silent mutations.
d The percentage was calculated as 100 (number of positive V-heavy genes/number of VH186.2 genes sequenced).
e The number of VH186.2 genes sequenced.
f The number of VH186.2 genes which had more than one mutation.
g Expected R/S ratio if mutagenesis was random.
h No silent mutations.
now reached the conclusion that some of the IgG1 mem- These results strongly suggest that IgM memory B cells
can be also generated without GC formation.ory B cells can be generated independently of GC for-
mation. IgG1 and IgM memory B cells without somatic hyper-
mutation in the V-heavy genes were generated withoutIgG1 memory B cells in the spleen of Bcl6/RM pro-
duced Abs with high affinity, whereas the affinity of Abs GC formation in the spleen of Bcl6/RM. These memory
B cells were selected by the antigen since more thanproduced by IgG1 memory B cells in Bcl6/RM is signif-
icantly low. Accordingly, somatic hypermutation is not 85% of these rearranged VH186.2 genes encoded Tyr
at position 99 (Weiss and Rajewsky, 1990; Jacob anddetected in the V-heavy genes in IgG1 memory B cells
of Bcl6/RM. These results clearly indicate that some Kelsoe, 1992). Thus, the clonal selection of memory B
cells seems to be intact in Bcl6/RM. However, theIgG1 memory B cells can be generated independently
of somatic hypermutation. Thus, high-affinity interaction affinities of the primary IgG1 Abs did not increase in
Bcl6/RM until 70 days after immunization becauseof surface Ig with Ags is dispensable for the differentia-
tion of memory B cells. In fact, nonmutated IgG1 memory somatic hypermutation is missing in the generation of
memory B cells in Bcl6/RM. In this context, the previ-B cells were detected in the spleen of normal mice after
primary immunization (Takahashi et al., 2001). We also ous observations in LT-deficient mice immunized with
soluble TD-Ags with adjuvant argued that the generationconfirmed that approximately 10% of IgG1 memory B
cells (three out of 27 clones) have a nonmutated V-heavy of IgG1 memory B cells was supported by accumulation
of somatic hypermutation and antigen-driven selectiongene in the spleen of Bcl6/RM 60 days after immuniza-
tion. These results are in agreement with previous obser- in the absence of GC formation (Matsumoto et al., 1996).
The controversy between the previous observations andvations that the memory compartment in normal mice
is mostly established by precursors generated from the ours does not appear to be due to the dose of the
antigens used for primary immunization, since no so-early GCs and that IgG1 memory B cells accumulated
somatic hypermutation to a much lesser extent than matic hypermutation occurred in memory B cells of
Bcl6/RM immunized with higher doses (100 g) ofthat of late GC B cells (Schittek and Rajewsky, 1990;
Takahashi et al., 2001). Therefore, normal mice may also NP-CG (data not shown). Furthermore, LT-deficient
mice showed a dramatically impaired ability to generategenerate nonmutated memory B cells independently of
GC formation. There may be an alternative pathway for high-affinity IgG to NP, and somatic mutation of the
expressed IgG heavy gene was rarely detected whengeneration of memory B cells independent of GC forma-
tion and somatic hypermutation in addition to the con- NP-sheep red blood cells were used as an antigen in
the absence of adjuvant (Wang et al., 2000). Thus, GCventional GC pathway.
Other than IgG memory B cells, the recent observa- formation is important for somatic hypermutation and
affinity maturation.tions showed the evidence of IgM memory B cells car-
rying mutated V-heavy genes in mice (Claflin et al., 1987; It remains unknown at present whether Bcl6 defi-
ciency leads directly to loss of ability to somaticallyDell et al., 1989; White and Gray, 2000) and humans
(Klein, et al., 1998). In this context, we observed that mutate or whether this is indirect, via prevention of GC
formation. The mechanism of somatic hypermutationIgM B cells with mutated V-heavy genes were gener-
ated in the spleen of Bcl6/RM 60 days after immuniza- has not been clarified completely despite extensive
studies over the last two decades. Recently, a moleculartion (Table 2), thereby supporting the generation of IgM
memory B cells in normal mice. The titers of IgM anti- link between somatic hypermutation and Ig class
switching has been demonstrated in activation-inducedNP Abs in Bcl6/RM within 7 days after boosting ex-
ceeded the primary levels by 10-fold. Furthermore, cytidine deaminase (AID) deficiency (Muramatsu et al.,
2000; Revy et al., 2000). AID may be involved in thesplenic B cells from Bcl6/RM immunized with TD-Ags
produced 5-fold more IgM anti-NP Abs than those from regulation or catalysis of the DNA modification step of
both somatic hypermutation and Ig class switching.naive Bcl6/RM in the adoptive transfer experiments.
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biotinylated monoclonal Abs against B220 (RA3-6B2), Mac-1 (M1/Since the molecular link is not observed in Bcl6/RM,
70), Gr-1 (RB6-8C5), CD4 (GK1.5), CD8 (53-6.72), and TER119 werethe function of Bcl6 in GC B cells may not be related to
purchased from PharMingen (San Diego, CA) and used to detectthat of AID, suggesting that Bcl6 may not play a direct
lineage markers (Lin). Fluorescent isothiocyanate (FITC)-conjugated
role in the operation of somatic hypermutation. Further anti-Sca-1 (Ly6A/E) Ab was purchased from PharMingen. Biotinyl-
study is required to elucidate a role for Bcl6 in the gener- ated Abs were visualized using Streptavidin-phycoerythrin (PE)
ation of GC B cells. (PharMingen). For isolation of LinSca-1 cells from BM cells, total
BM cells from Bcl6/ or Bcl6/ littermates were stained with aIt has recently been reported that one of the target
cocktail of biotinylated monoclonal Abs against lineage markers forgenes of Bcl6, a transcriptional repressor, is the B lym-
20 min at 4C. After washing the cells three times with stainingphocyte-induced maturation protein (Blimp-1) (Shaffer
medium (phosphate-buffered saline with 3% fetal calf serum and
et al., 2000) and that overexpression of Blimp-1 stimu- 0.2 mM EDTA), the cells were treated with streptavidin-conjugated
lates terminal B cell differentiation (Messika et al., 1998). immunomagnetic beads (BioMag; Perceptive Diagnostics, Cam-
Thus, we expected large numbers of AFCs in the BM of bridge, MA) for 30 min to remove lineage marker highly positive
cells. The remaining cells were collected and stained with FITC-Bcl6/RM after immunization. However, the numbers
anti-Sca-1 Ab and Streptavidin-PE at 4C for 20 min. After washing,of AFCs producing IgG1 Abs were very low in the BM
the cells were resuspended in staining medium supplemented withof Bcl6/RM 14 and 60 days after immunization (Figure
propidium iodide (1 g/ml). The LinSca-1 cells were sorted by a4). Bcl6/RM produced control levels of primary IgG1
FACSVantage (Becton Dickinson, San Jose, CA).
Abs until 14 days after immunization (Figure 1), and the RAG1/ mice (8- to 16-week-old) were sublethally irradiated (4.0
primary IgG1 Abs were produced by IgG1-AFCs gener- Gy) and injected with 1.5–2  104 LinSca-1 cells from Bcl6/ or
ated in extrafollicular foci of Bcl6/RM after immuniza- Bcl6/ littermates. The reconstitutions were confirmed 8–12 weeks
after transplantation by identifying CD3 and B220 mature lympho-tion (Fukuda et al., 1997). These IgG1-AFCs may be
cytes in peripheral blood from Bcl6/RM and Bcl6/RM using flowshort-lived in agreement with previous observations (Ja-
cytometry. These mice were primed intraperitoneally with 50 g ofcob and Kelsoe, 1992; Smith et al., 1996) and may not
NP25-CG (Biosearch Technologies, Novato, CA) precipitated in alum.be able to migrate into the BM. Since the affinity of IgG1 Fifty micrograms of soluble NP25-CG were administered intrave-
Abs produced by AFCs in the BM of Bcl6/RM 14 days nously for the secondary challenge.
after immunization was already very high (NP2/NP25 
0.60) and since GC B cells were detected in the spleens Flow Cytometry and Memory Cell Analysis
of Bcl6/RM 7 days after immunization (Fukuda, et al., Single-cell suspensions were prepared from spleens, and then the
red blood cells were depleted by incubation in 0.83% NH4Cl. Cells1997), the majority of IgG1-AFCs in the BM may be
were blocked with 20 g/ml of anti-FcRII/III (2.4G2; PharMingen)derived from GC B cells as previously described (Smith
and incubated with a mixture of biotinylated Abs against IgM, CD90,et al., 1997; Takahashi et al., 1998).
CD43, Mac-1, TER119, and IgD (PharMingen) (CD90mix) to excludeIn contrast, AFCs producing IgM Abs were clearly
naive B cells, B-1 cells, myeloid cells, erythroid cells, and T cells
detected in the BM of both Bcl6/RM and Bcl6/RM from the analysis (CD90mix gated: R1). After washing, the cells
14 days after immunization. The numbers of IgM-AFCs were incubated for 30 min with a mixture of Abs (FITC-labeled anti-
decreased in the BM of both Bcl6/RM and Bcl6/RM IgG1 [PharMingen], PE-conjugated NIP26-BSA [NIP-BSAPE], allo-
phycocyanin [APC]-conjugated anti-CD38 [kindly provided by Dr.with time, and the numbers of IgM-AFCs in Bcl6/RM
K. Miyake, The University of Tokyo], APC/Cy7-labeled anti-B220were larger than those in Bcl6/RM 60 days after immu-
[Caltag Laboratories, Burlingame, CA]) and with ECD-conjugatednization. These larger numbers of IgM-AFCs in the BM
streptavidin (Immunotech, Marseille, France) and propidium iodideof Bcl6/RM may explain the higher titer of IgM anti-
(1g/ml). Cells were analyzed and sorted by a FACSVantage (Becton
NP Abs in Bcl6/RM 70 days after immunization (Figure Dickinson) equipped with appropriate filters for five-color analysis
1D). These results suggest that the majority of IgM-AFCs in a dual argon laser (488 nm)/Helium Neon laser (633 nm) system.
in the BM may be derived from IgM-AFCs in extrafollicu- At least one million total events were collected for each file and
then analyzed using CELL Quest software (Beckton Dickinson).lar foci but not from GC B cells, and that a half-life of
IgM-AFCs in the BM is clearly shorter than that (approxi-
Adoptive Transfer Experimentsmately 100 days) of long-lived IgG1-AFCs in the BM as
Splenic B cells were enriched by depleting non-B lineage cells fromdescribed previously (Manz et al., 1997; Slifka et al.,
spleen cells of Bcl6/RM and Bcl6/RM immunized with NP-CG.1998).
In brief, spleen cells were incubated with a mixture of biotinylated
In summary, Bcl6-deficient mature B cells can differ- monoclonal Abs to CD3, CD4, CD8, TER119, and Mac-1. These cells
entiate into IgM and IgG1 memory B cells in the absence were subsequently reacted with streptavidin-coated immunomag-
of GC formation. However, these memory B cells have netic beads (Miltenyi Biotec, Gladbach, Germany). Labeled cells
were removed by applying them in a magnetic field using an auto-no somatic hypermutation in the V-heavy gene. There-
MACS system (Miltenyi Biotec). The resulting B cell fractionfore, Bcl6 and GC formation is essential for somatic
contained 95% of B220 cells and 0.5% of CD3 cells. Splenichypermutation, and nonmutated memory B cells can be
T cells were also enriched in a similar manner with monoclonal Absgenerated without GC formation.
to B220, TER119, and Mac-1 from spleen cells of C57BL/6 mice
immunized with CG in alum. Resulting T cells contained 0.5% ofExperimental Procedures
B220 cells. The mixture of separated B (3  107 ) and T (1.5  107 )
cells were injected i.v. into RAG1/ mice. The mice were immunizedMice
with 50 g of soluble NP-CG 12 hr after transplantation.C57BL/6 mice were purchased from Japan SLC Co. Ltd. (Hama-
matsu, Japan). Bcl6/ (Yoshida et al., 1999) and RAG1/ (Mom-
In Vitro Secondary Antibody Responsesbaerts et al., 1992) were as described. All these mice were main-
The in vitro secondary antibody production was done as describedtained under specific pathogen-free conditions in the animal center
(Schittek and Rajewsky, 1990). In brief, spleen cells were isolatedof the Graduate School of Medicine, Chiba University.
from NP-CG-immunized Bcl6/RM and Bcl6/RM, stained and
sorted for NIP binding CD90mix/IgG1/CD38 B cells as describedGeneration of Bcl6/RM and Immunizations
in Flow Cytometry and Memory Cell Analysis using a FACSVantageA primitive hematopoietic stem cell fraction in BM cells was isolated
by the previously described method (Okada et al., 1999). In brief, (Beckton Dickinson). NIP binding CD90mix/IgG1/CD38 B cells
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(250–500 cells) were sorted into 96-well microtiter plates, which Allen, D., Simon, T., Sablitzky, F., Rajewsky, K., and Cumano, A.
(1988). Antibody engineering for the analysis of affinity maturationcontained CD4 T cells (2  105 cells per well) from PE-immunized
mice. These cells were cultured in RPMI1640 medium (Sigma Chemi- of an anti-hapten response. EMBO J. 7, 1995–2001.
cal Co., St Louis, MO) supplemented with 10% FCS for 14 days. Banks, T.A., Rouse, B.T., Kerley, M.K., Blair, P.J., Godfrey, V.L.,
Kuklin, N.A., Bouley, D.M., Thomas, J., Kanangat, S., and Mucenski,
BrdU Incorporation Assay M.L. (1995). Lymphotoxin-deficient mice: effects on secondary
Memory B cells (NIP binding CD90mix/IgG1/CD38) and pre-B lymphoid organ development and humoral immune responsiveness.
cells (B220/IgM) were sorted from spleen cells and BM cells of J. Immunol. 155, 1685–1693.
BrdU (Roche Diagnostics, Indianapolis, IN) fed (for 3 days, 0.8 mg/ Berek, C., Berger, A., and Apel, M. (1991). Maturation of the immune
ml) NP-CG-immunized Bcl6/RM and Bcl6/RM, respectively, as response in germinal centers. Cell 67, 1121–1129.
described (Maruyama et al., 2000). These sorted cells were spread
Bothwell, A.L., Paskind, M., Reth, M., Imanishi-Kari, T., Rajewsky,on a slide glass by Cytospin (Shandon Southern Instruments Inc,
K., and Baltimore, D. (1982). Heavy chain variable region contributionSewickley, PA) and fixed with cold acetone for 10 min. These cells
to the NPb family of antibodies: somatic mutation evident in a  2awere incubated with 2 N HCl for 1 hr and then neutralized in 0.1 M
variable region. Cell 24, 625–637.disodium tetraborate (pH 9.0). Treated cells were incubated with
Castigli, E., Alt, F.W., Davidson, L., Bottaro, A. Mizoguchi, E., Bhan,FITC-conjugated anti-BrdU Abs (BD Bioscience, San Diego, CA)
A.K., and Geha, R.S. (1994). CD40-deficient mice generated by re-and propidium iodide (1 g/ml), mounted in GEL/MOUNT (Biomeda,
combination-activating gene-2-deficient blastocyst complementa-Foster City, CA), and counted under a fluorescence microscope.
tion. Proc. Natl. Acad. Sci. USA 91, 12135–12139.
ELISA and ELISPOT Assays Cattoretti, G., Chang, C.-C., Cechova, K., Zhang, J., Ye, B.H., Falini,
IgM and IgG1 Abs in sera and AFCs producing anti-NP Abs in the B., Louie, D.C., Offit, K., Chaganti, R.S.K., and Dalla-Favera, R.
BM were detected using ELISA and ELISPOT, respectively. The (1995). BCL-6 protein is expressed in germinal-center B cells. Blood
relative affinity of those Abs was measured using low (NP2-BSA) or 86, 45–53.
high (NP25-BSA) coupling ratios of NP-BSA (Biosearch Technologies) Chang, C.C., Ye, B.H., Chaganti, R.S., and Dalla-Favera, R. (1996).
as described (Takahashi et al., 1998). BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcrip-
tional repressor. Proc. Natl. Acad. Sci. USA 93, 6947–6952.
Single-Cell Sequence Analysis of the V-heavy Genes
Claflin, J.L., Berry, J., Flaherty, D., and Dunnick, W. (1987). Somatic
Single NIP binding IgG1 B cells or NIP binding IgM B cells were
evolution of diversity among anti-phosphocholine antibodies in-
clone sorted using a FACSVantage with Clon-cyte (Beckton Dickin-
duced with Proteus morganii. J. Immunol. 138, 3060–3068.
son). Single cells were directly sorted into PCR tubes (Takara, Japan)
Croix, D.A., Ahearn, J.M., Rosengard, A.M., Han, S., Kelsoe, G.,containing the One Step RT-PCR reaction mix (One step RT-PCR
Ma, M., and Carrol, C. (1996). Antibody response to a T-dependentkit; QIAGEN, Hilden, Germany), 10 U RNase Out (Life Technologis,
antigen requires B cell expression of complement receptors. J. Exp.Rockville, MD), 50 ng tRNA (Roche Diagnostics, Mannheim, Ger-
Med. 183, 1857–1864.many), and 0.6 M gene specific primers (VH186.2F: 5	-TCTTG
GCAGCAACAGCTACA-3	 and C1R: 5	-GGATCCAGAGTTCCAGGT Cumano, A., and Rajewsky, K. (1985). Structure of primary anti-
(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in normal and idio-CACT-3	, or CR: 5	-GAAGACATTTGGGAAGGACTGACT-3	) (Mura-
matsu et al., 2000). The single B cell in the reaction mix was sub- typically suppressed C57BL/6 mice. Eur. J. Immunol. 15, 512–520.
jected to one step RT-PCR immediately using the protocol of the Dell, C.L., Lu, Y.X., and Claflin, J.L. (1989). Molecular analysis of
manufacturer. One step RT-PCR product was then directly se- clonal stability and longevity in B cell memory. J. Immunol. 143,
quenced using a sequencing primer (VH186.2 int.: 5	-CCAGGGG 3364–3370.
CCAGTGGATAGAC-3	). The nucleotide sequences of the cloned
Dent, A.L., Shaffer, A.L., Yu, X., Allman, D., and Staudt, L.M. (1997).
V-heavy genes were determined by automated sequencing using
Control of inflammation, cytokine expression, and germinal center
an ABI PRISM 3100 DNA sequencer (PE Biosystems, Foster City,
formation by BCL-6. Science 276, 589–592.
CA). One step RT-PCR and the automatic cell dispensing unit
Deweindt, C., Albagli, O., Bernardin, F., Dhordain, P., Quief, S., Lan-avoided contamination of DNAs during RT-PCR steps and reduced
toine, D., Kerckaert, J.P., and Leprince, D. (1995). The LAZ3/BCL6PCR steps to a single round. The direct sequencing method dramati-
oncogene encodes a sequence-specific transcriptional inhibitor: acally reduced detection of sequence errors by PCR.
novel function for the BTB/POZ domain as an autonomous repress-
ing domain. Cell Growth Differ. 6, 1495–1503.Acknowledgments
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